These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 29781383)

  • 21. A conventional and magnetization transfer MRI study of the cervical cord in patients with MS.
    Filippi M; Bozzali M; Horsfield MA; Rocca MA; Sormani MP; Iannucci G; Colombo B; Comi G
    Neurology; 2000 Jan; 54(1):207-13. PubMed ID: 10636149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
    Magon S; Tsagkas C; Gaetano L; Patel R; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Stippich C; Kappos L; Chakravarty MM; Sprenger T
    J Neurol; 2020 May; 267(5):1536-1546. PubMed ID: 32040710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis.
    Mariottini A; Stack EH; Nair G; Nozzoli C; Wu T; Marchi L; Boncompagni R; Repice AM; Fainardi E; Pasquale FD; Carlesi E; Saccardi R; Jacobson S; Massacesi L
    Mult Scler Relat Disord; 2024 Aug; 88():105745. PubMed ID: 38996712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
    Bischof A; Papinutto N; Keshavan A; Rajesh A; Kirkish G; Zhang X; Mallott JM; Asteggiano C; Sacco S; Gundel TJ; Zhao C; Stern WA; Caverzasi E; Zhou Y; Gomez R; Ragan NR; Santaniello A; Zhu AH; Juwono J; Bevan CJ; Bove RM; Crabtree E; Gelfand JM; Goodin DS; Graves JS; Green AJ; Oksenberg JR; Waubant E; Wilson MR; Zamvil SS; ; Cree BAC; Hauser SL; Henry RG
    Ann Neurol; 2022 Feb; 91(2):268-281. PubMed ID: 34878197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.
    Laule C; Vavasour IM; Zhao Y; Traboulsee AL; Oger J; Vavasour JD; Mackay AL; Li DK
    Mult Scler; 2010 Jun; 16(6):670-7. PubMed ID: 20558500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous diffuse brain atrophy independent of relapse as a hallmark of multiple sclerosis beginning from relapsing-remitting stage.
    Akaishi T; Fujimori J; Yokote H; Nakashima I
    Clin Neurol Neurosurg; 2024 Jul; 242():108342. PubMed ID: 38772279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of endogenous antiradical protective system in multiple sclerosis.
    Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
    Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease. Correlation between MRI parameters and clinical course.
    Bonek R; Orlicka K; Maciejek Z
    Neurol Neurochir Pol; 2007; 41(3):229-33. PubMed ID: 17629816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
    Haider L; Prados F; Chung K; Goodkin O; Kanber B; Sudre C; Yiannakas M; Samson RS; Mangesius S; Thompson AJ; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Chard DT; Barkhof F
    Brain; 2021 Jun; 144(5):1384-1395. PubMed ID: 33880511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
    Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
    Samson RS; Cardoso MJ; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ron M; Ourselin S; Miller DH; Chard DT
    Mult Scler; 2014 Sep; 20(10):1322-30. PubMed ID: 24552746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sclerosis lesions and atrophy in the spinal cord: Distribution across vertebral levels and correlation with disability.
    Bussas M; El Husseini M; Harabacz L; Pineker V; Grahl S; Pongratz V; Berthele A; Riederer I; Zimmer C; Hemmer B; Kirschke JS; Mühlau M
    Neuroimage Clin; 2022; 34():103006. PubMed ID: 35468568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis.
    Tsagkas C; Huck-Horvath A; Cagol A; Haas T; Amann M; Barakovic M; Ruberte E; Melie-Garcia L; Weigel M; Pezold S; Schlaeger R; Kuhle J; Sprenger T; Kappos L; Bieri O; Cattin P; Granziera C; Parmar K
    Mult Scler Relat Disord; 2023 Mar; 71():104545. PubMed ID: 36758461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
    Sormani MP; Rovaris M; Comi G; Filippi M
    Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years.
    Turner B; Lin X; Calmon G; Roberts N; Blumhardt LD
    Mult Scler; 2003 Feb; 9(1):21-7. PubMed ID: 12617263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis.
    Tsagkas C; Huck-Horvath A; Cagol A; Haas T; Barakovic M; Amann M; Ruberte E; Melie-Garcia L; Weigel M; Pezold S; Schlaeger R; Kuhle J; Sprenger T; Kappos L; Bieri O; Cattin P; Granziera C; Parmar K
    Mult Scler; 2023 May; 29(6):702-718. PubMed ID: 36550626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
    Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.